Article Abstract

How will nanotechnology lead to better control of asthma?

Authors: Bumhee Yang, Hayoung Choi, Sang-Heon Kim, Ho Joo Yoon, Hyun Lee


Asthma is a common inflammatory disease of the lungs characterized by reversible airway obstruction, bronchial hyper-responsiveness, and chronic airway inflammation (1). The most widely used therapies for asthma include inhaled corticosteroids and bronchodilators (short- or long-acting β2-adrenergic agonists or muscarinic antagonists). Although most patients with asthma respond well to inhaled corticosteroids, asthma control is poor in some patients who require maximal dosages (2).

Article Options

Download Citation